- General
- Ganga Pharmaceuticals Limited Prospectus
- GID for Ganga Pharmaceuticals limited IPO
- Ganga Pharma R Form_2A
- Results for September 30, 2025
- Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI Regulations 2015
- Intimation of Board Meeting
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Non Applicablity of C.G Report for June 2025
- Non Applicablity of C.G Report for September 2025
- Share Reco Report for June 2025
- Proceedings and Voting Results and Scruntinizer Report for AGM held on September 20, 2025
- Shareholding Pattern for September 2025
- Integrated Governance for June 2025
- Integrated Governance for September 2025
- Balance Sheet
- Annual Return
- Annual Report
- Annual Report 2024-25
- Annual Report 2023-24
- Annual Report 2022-23
- Annual Report 2021-22
- Annual Report 2020-21
- Annual Report 2019-20
- Annual Report 2018-19
- Annual Report 2017-18
- Annual Report 2016-17
- Annual Report 2015-16
- half yearly results
- Outcome of Results Sept 2023
- Outcome of Result March 2023
- Audited financial Results for half year ended 31.03.2016
- Financial Results Half Year Ended September 2016
- Audited financial Results for half year and year ended 31.03.2017
- Revised Audited financial Results for half year and year ended
31.03.2017 - Financial Results for half year 30.09.2017
- Audited financial Results for half year and year ended 31.03.2018
- Financial Results Half Year Ended September 2016
- Financial Results Half Year Ended September 2018
- Financial Results Half Year Ended March 2019
- Financial Results Half Year Ended September 2019
- Composition of Board & Committees
- Terms & Conditions Of Independent Directors
- Investor Redressal Forum
- Name, address & Contact Person of the Company
Name: Ganga Pharmaceuticals Limited
Address: Gangatat, Dhanvantri Marg, Gopchar Pada,
Virar (E) – 401 305, Maharashtra, India.
Tel No: +91 8452 49222 / +91 99678 40111;
Fax No: +91 250 2528602;
Email: ayurvedganga@gmail.com
Website: www.ayurvedganga.com
Contact Person: Mr Bharat Sharma, Compliance Officer.Details of Registrar & Share
Transfer AgentName: Karvy Computershare Private Limited
Address: Karvy Selenium, Tower B,
Plot 31-32, Gachibowli,
Financial District, Nanakramguda,
Hyderabad – 500 032.
Tel No: 1-800-3454001 / +91 40 6716 2222
Fax No: +91 40 23431551
Email: einward.ris@karvy.com
Website: www.karisma.karvy.com
Contact Person : Mr. M Murali Krishna.
- Name, address & Contact Person of the Company
- Shareholding Pattern
- Others
- Covering Letter
- BM Outcome Allotment of Shares
- Resgination of CS on BSE
- Notice of Board meeting of Ganga Pharmaceuticals Limited
- Outcome of Board meeting Ganga Revised filed
- Outcome of Board meeting 27.05.2016
- Outcome of Board meeting 16.08.2016
- Outcome of Board meeting 12.07.2018
- Outcome of Board meeting 25.07.2019
- Outcome of Board meeting 27.06.2020
- Notice of Board meeting Sep 2023
- Notice of Board meeting May 2018
- Notice of Board meeting May 2017
- Notice of Board meeting Nov 2017
- Notice of Board meeting May 2016
- Notice of Board meeting Octomber 2016
- Notice of Board meeting November 2018
- Notice of Board meeting May 2019
- Notice of Board meeting Nov 2019
- Notice of Board meeting June 2020
- Notice of Board meeting September 2021
- Notice of Board meeting May 2022
- Proceedings of AGM of Ganga Pharmaceuticals Limited
- Notice of AGM of Ganga Pharmaceuticals Limited
- AGM voting result of Ganga Pharmaceuticals Limited
- Publication of Notice of AGM to be held on 26.08.2019 in newspaper
- clippings of the Notice of AGM published in the newspapers
- Newspaper Advertisement of Notice 2017
- Notice of AGM 2016
- Newspaper Advertisement of Notice 2016
- Notice of Book Closure of Ganga Pharmaceuticals Limited
- Scrutinizer Report AGM held on 16.09.2016
- Scrutinizer Report 2018
- Proceeding of AGM 2018
- Note on DPT
- Certificate under Regulation 74(5) of the SEBI
- CG Non-applicability September 2021
- Closure of trading September 2021
- 40(9) March 2022
- reg7(3) March 2022
- Outcome & Result March 2022
- Investor complaints March 2022
- Trading Closure March 2022
- Statement of Deviation or Variation
- Outcome BM
- Code & Policies
- Whistler Blower Policy
- Board Diversity Policy
- Code of conduct for prevention of Insider Trading
- Code of Conduct
- Policy for Preservation of Documents
- Policy for Determination of Materiality of Events
- Performance evaluation policy
- Nomination, Remuneration and Evaluation Policy
- Succession Policy
- Policy on Related Party Transactions
- Policy on Material Subsidiaries
- Policy on fair disclosure of Unpublished Price Sensitive Information
- Form no MGT – 7
- Valuation Report
- Notice of EGM
- Investor KYC documents
- Disclosure under Regulation 46
- Terms and Conditions of appointment of independent directors.
- Details of familiarization programmes imparted to independent directors
- Items in sub-regulation (1) of regulation 47
- Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015 for
Publication of Notice of the 33″ Annual General Meeting and E-Voting in Newspapers. - Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015 for
Publication of Notice of the 31at Annual General Meeting and E-Voting in Newspapers. - notice of AGM_Paper Ad_AM
- notice of AGM_Paper Ad_FE
- Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015 for
- Disclosure of contact details of key managerial personnel who are authorized for
the purpose of determining materiality of an event or information.-- Name: Mr. Anagh Sharma
Address: Gangatat, Dhanvantri Marg, Gopcharpada,
Virar (E) – 401 305, Maharashtra, India.
Tel No: 0250-6098333 / 444 / 666 / 502
Email: ayurvedganga@gmail.com / gplvirar@gmail.com / gangapharmaltd@gmail.com
Website: www.ayurvedganga.com
- Name: Mr. Anagh Sharma
- Annual return as provided under section 92 of the Companies Act, 2013 and the
rules made thereunder. - Disclosures under sub-regulation (8) of regulation 30 of these regulations
- Resignation of Mr. Sanjay V. Kulkarni, as an Executive Director of the
Company - Adoption of Code of Fair Disclosure under SEBI (Prohibition of Insider
- Intimation of Resignation of Chief Financial Officer
- Intimation of the circular resolution passed by the Board of Directors
- Intimation under Regulation 30 of the SEBI (Listing Obligation and
Disclosure Requirements) Regulations, 2015, - Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015 for
Publication of Notice of the 33″ Annual General Meeting and E-Voting in Newspapers. - Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015 for
Publication of Notice of the 31st Annual General Meeting and E-Voting in Newspapers. - Notice of Book Closure and Annual General Meeting
- Resignation of Mr. Harish Bhagwandas, as an Independent Director of the
Company
- Resignation of Mr. Sanjay V. Kulkarni, as an Executive Director of the
- Financial Information
- Notice of Board Meeting
- Form ISR-4
